The Oncology Institute Inc (TOI)
0.3096
+0.01
(+3.41%)
USD |
NASDAQ |
Sep 27, 16:00
0.3079
0.00 (0.00%)
Pre-Market: 20:00
Oncology Institute SG&A Expense (TTM): 112.62M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 112.62M |
March 31, 2024 | 113.47M |
December 31, 2023 | 113.85M |
September 30, 2023 | 115.33M |
June 30, 2023 | 119.09M |
March 31, 2023 | 118.71M |
December 31, 2022 | 119.69M |
September 30, 2022 | 138.36M |
Date | Value |
---|---|
June 30, 2022 | 119.13M |
March 31, 2022 | 101.99M |
December 31, 2021 | 83.36M |
September 30, 2021 | 76.69M |
June 30, 2021 | 64.11M |
March 31, 2021 | 61.44M |
December 31, 2020 | 59.10M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
59.10M
Minimum
Dec 2020
138.36M
Maximum
Sep 2022
101.13M
Average
113.47M
Median
Mar 2024
SG&A Expense (TTM) Benchmarks
Encompass Health Corp | 3.007B |
Pediatrix Medical Group Inc | 227.23M |
US Physical Therapy Inc | -- |
Kindly MD Inc | 5.409M |
Concentra Group Holdings Parent Inc | 145.48M |